1. Home
  2. TRMK vs DYN Comparison

TRMK vs DYN Comparison

Compare TRMK & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trustmark Corporation

TRMK

Trustmark Corporation

HOLD

Current Price

$42.28

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$18.53

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRMK
DYN
Founded
1889
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
3.0B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TRMK
DYN
Price
$42.28
$18.53
Analyst Decision
Buy
Strong Buy
Analyst Count
2
14
Target Price
$43.50
$37.00
AVG Volume (30 Days)
394.6K
2.3M
Earning Date
04-21-2026
03-02-2026
Dividend Yield
2.38%
N/A
EPS Growth
1.93
N/A
EPS
3.70
N/A
Revenue
N/A
N/A
Revenue This Year
$9.49
N/A
Revenue Next Year
$5.17
N/A
P/E Ratio
$11.37
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.81
$7.01
52 Week High
$45.43
$25.00

Technical Indicators

Market Signals
Indicator
TRMK
DYN
Relative Strength Index (RSI) 51.81 56.31
Support Level $36.46 $18.32
Resistance Level $43.29 $20.08
Average True Range (ATR) 0.99 1.19
MACD 0.10 0.11
Stochastic Oscillator 80.80 59.52

Price Performance

Historical Comparison
TRMK
DYN

About TRMK Trustmark Corporation

Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: